Medtronic plc (MDT) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Medtronic financial statements at a glance

Medtronic reported revenue of $33.54 billion for fiscal year 2025 (ended April 30, 2025), up 3.6% from fiscal year 2024. Net income was $4.66 billion, a net margin of 13.9%, and diluted earnings per share were $3.61.

At the end of fiscal year 2025 it had total assets of $91.68 billion, total liabilities of $43.42 billion and shareholders' equity of $48.02 billion, with cash and short-term investments of $8.97 billion and total debt of $28.52 billion.

Its operations brought in $7.04 billion of cash; capital spending was $1.86 billion, leaving free cash flow of $5.19 billion.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended April 30, 2025.

MDT logo

Medtronic plc

MDTIreland
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
33.54B
Prev Year: 32.36B
YoY: +3.6%
Operating Revenue
33.54B
Prev Year: 32.36B
YoY: +3.6%
Total Unusual Items Excluding Goodwill
-584.00M
Prev Year: -375.00M
YoY: -55.7%
Total Unusual Items
-584.00M
Prev Year: -375.00M
YoY: -55.7%
Normalized EBITDA
9.80B
Prev Year: 8.58B
YoY: +14.3%
Tax Rate for Calcs
0.166
Prev Year: 0
Tax Effect of Unusual Items
-96.94M
Prev Year: -87.75M
YoY: -10.5%
Cost of Revenue
11.63B
Prev Year: 11.22B
YoY: +3.7%
Gross Profit
21.91B
Prev Year: 21.15B
YoY: +3.6%
Operating Expense
15.37B
Prev Year: 15.63B
YoY: -1.7%
Selling General and Administrative
10.85B
Prev Year: 10.74B
YoY: +1.1%
Research and Development
2.73B
Prev Year: 2.73B
YoY: -0.1%
Depreciation Amortization Depletion
1.81B
Prev Year: 1.69B
YoY: +6.7%
Depreciation and amortization
1.81B
Prev Year: 1.69B
YoY: +6.7%
Amortization
1.81B
Prev Year: 1.69B
YoY: +6.7%
Amortization of Intangibles
1.81B
Prev Year: 1.69B
YoY: +6.7%
Other Operating Expenses
-23.00M
Prev Year: 464.00M
YoY: -105.0%
Operating Income
6.54B
Prev Year: 5.52B
YoY: +18.5%
Net Non Operating Interest Income Expense
-729.00M
Prev Year: -719.00M
YoY: -1.4%
Non-operating Interest Expense
729.00M
Prev Year: 719.00M
YoY: +1.4%
Non-operating Interest Income
-
Other Income Expense
-182.00M
Prev Year: 37.00M
YoY: -591.9%
Special Income Charges
-584.00M
Prev Year: -375.00M
YoY: -55.7%
Gain on Sale of Securities
-
Restructuring and Mergers Acquisition
267.00M
Prev Year: 226.00M
YoY: +18.1%
Other Special Charges
317.00M
Prev Year: 149.00M
YoY: +112.8%
Other Non-operating Income (expense)
402.00M
Prev Year: 412.00M
YoY: -2.4%
Pre-tax Income
5.63B
Prev Year: 4.84B
YoY: +16.4%
Provision for Income Taxes
936.00M
Prev Year: 1.13B
YoY: -17.4%
Net Income Common Stockholders
4.66B
Prev Year: 3.68B
YoY: +26.8%
Net Income
4.66B
Prev Year: 3.68B
YoY: +26.8%
Net Income Including Non-Controlling Interests
4.69B
Prev Year: 3.71B
YoY: +26.6%
Net Income from Continuing Operations
4.69B
Prev Year: 3.71B
YoY: +26.6%
Noncontrolling Interests
-29.00M
Prev Year: -28.00M
YoY: -3.6%
Diluted NI Available to Com Stockholders
4.66B
Prev Year: 3.68B
YoY: +26.8%
Basic EPS
3.63
Prev Year: 2.77
YoY: +31.0%
Diluted EPS
3.61
Prev Year: 2.76
YoY: +30.8%
Weighted Average Shares (basic)
1.29B
Prev Year: 1.33B
YoY: -3.2%
Weighted Average Shares (diluted)
1.29B
Prev Year: 1.33B
YoY: -3.0%
Total Operating Income as Reported
5.96B
Prev Year: 5.14B
YoY: +15.8%
Total Expenses
27.00B
Prev Year: 26.84B
YoY: +0.6%
Net Income from Continuing and Discontinued Operation
4.66B
Prev Year: 3.68B
YoY: +26.8%
Normalized Income
5.15B
Prev Year: 3.96B
YoY: +29.9%
Interest Expense
729.00M
Prev Year: 719.00M
YoY: +1.4%
Interest Income
-
Net Interest Income
-729.00M
Prev Year: -719.00M
YoY: -1.4%
EBIT
6.36B
Prev Year: 5.56B
YoY: +14.4%
EBITDA
9.22B
Prev Year: 8.20B
YoY: +12.4%
Reconciled Cost of Revenue
10.58B
Prev Year: 10.26B
YoY: +3.1%
Reconciled Depreciation
2.86B
Prev Year: 2.65B
YoY: +8.1%
Net Income from Continuing Operation Net Minority Interest
4.66B
Prev Year: 3.68B
YoY: +26.8%
Values in USD

Medtronic key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$33.5B$32.4B$31.2B$31.7B$30.1B
Gross profit$21.9B$21.1B$20.5B$21.5B$19.6B
Operating income$6.5B$5.5B$5.8B$5.9B$4.9B
Net income$4.7B$3.7B$3.8B$5.0B$3.6B
Diluted EPS$3.61$2.76$2.82$3.73$2.66
Total assets$91.7B$90.0B$90.9B$91.0B$93.1B
Total liabilities$43.4B$39.6B$39.3B$38.3B$41.5B
Shareholders' equity$48.0B$50.2B$51.5B$52.6B$51.4B
Cash and short-term investments$9.0B$8.0B$8.0B$10.6B$10.8B
Total debt$28.5B$25.0B$24.4B$24.1B$26.4B
Operating cash flow$7.0B$6.8B$6.0B$7.3B$6.2B
Capital spending$1.9B$1.6B$1.5B$1.4B$1.4B
Free cash flow$5.2B$5.2B$4.6B$6.0B$4.9B

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2014.

Questions and answers

What was Medtronic's revenue in fiscal year 2025?

$33.54 billion, up 3.6% from $32.36 billion in fiscal year 2024.

How much profit does Medtronic make?

Medtronic reported net income of $4.66 billion for fiscal year 2025 (13.9% of revenue); operating income was $6.54 billion.

How much cash and debt does Medtronic have?

At the end of fiscal year 2025: cash and short-term investments of $8.97 billion and total debt of $28.52 billion.

What is Medtronic's free cash flow?

$5.19 billion in fiscal year 2025 (operating cash flow of $7.04 billion minus capital spending of $1.86 billion).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube